Measurement of tumor markers in chronic hemodialysis patients
المؤلفون المشاركون
Tzitzikos, G.
Saridi, M.
Filippopoulou, T.
Makri, A.
Goulioti, A.
Stavropoulos, T.
Stamatiou, K.
المصدر
Saudi Journal of Kidney Diseases and Transplantation
العدد
المجلد 21، العدد 1 (28 فبراير/شباط 2010)، ص ص. 50-53، 4ص.
الناشر
تاريخ النشر
2010-02-28
دولة النشر
السعودية
عدد الصفحات
4
التخصصات الرئيسية
الموضوعات
الملخص EN
Tumor markers are widely used for screening certain tumors, however, their use in chronic hemodialysis (HD) patients in hemodialysis has been a controversial issue.
To determine the reliability of the tumor markers, CA 15-3, CA 19-9, CA 125, Alpha-Fetoprotein and Carcinoembryonic antigen (CEA), in chronic HD patients, and the impact of active hepatitis C on the variation of tumor markers values, we studied 30 patients (16 men and 14 women) aged from 40 to 78 years old (mean age: 54 ± 5 years), on intermittent hemodialysis (with a mean duration of 10.5 years), and clinically free from neoplastic disease.
The control group included 30 healthy volunteers.
All subjects were of Greek origin and residents of the Korinthos region.
The tumor markers were measured once in the control group and before and afterwards the hemodialysis, in the study group.
Alpha fetoprotein was within normal limits in all the study patients, CA 125 was slightly increased in one (3.3%) patient, CA 15-3 levels were twice normal in 4 (13%) patients, CA 19-9 levels were twice normal in 5 (16%) patients, and CEA levels were twice normal in 4(13%) patients.
More than half (7/13) of anti HCV positive and all Australian antigen positive patients had abnormal serum levels of CA 153 and CA 125 after hemodialysis treatment.
We conclude that measurement of some tumor markers such as alfa-fetoprotein may be beneficial in HD patients.
However, the elevated levels of other markers including CA 15-3 and CA 125 are not specific for neoplasms and related to active hepatitis C.
نمط استشهاد جمعية علماء النفس الأمريكية (APA)
Tzitzikos, G.& Saridi, M.& Filippopoulou, T.& Makri, A.& Goulioti, A.& Stavropoulos, T.…[et al.]. 2010. Measurement of tumor markers in chronic hemodialysis patients. Saudi Journal of Kidney Diseases and Transplantation،Vol. 21, no. 1, pp.50-53.
https://search.emarefa.net/detail/BIM-63387
نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)
Tzitzikos, G.…[et al.]. Measurement of tumor markers in chronic hemodialysis patients. Saudi Journal of Kidney Diseases and Transplantation Vol. 21, no. 1 (Feb. 2010), pp.50-53.
https://search.emarefa.net/detail/BIM-63387
نمط استشهاد الجمعية الطبية الأمريكية (AMA)
Tzitzikos, G.& Saridi, M.& Filippopoulou, T.& Makri, A.& Goulioti, A.& Stavropoulos, T.…[et al.]. Measurement of tumor markers in chronic hemodialysis patients. Saudi Journal of Kidney Diseases and Transplantation. 2010. Vol. 21, no. 1, pp.50-53.
https://search.emarefa.net/detail/BIM-63387
نوع البيانات
مقالات
لغة النص
الإنجليزية
الملاحظات
Includes bibliographical references : p. 53.
رقم السجل
BIM-63387
قاعدة معامل التأثير والاستشهادات المرجعية العربي "ارسيف Arcif"
أضخم قاعدة بيانات عربية للاستشهادات المرجعية للمجلات العلمية المحكمة الصادرة في العالم العربي
تقوم هذه الخدمة بالتحقق من التشابه أو الانتحال في الأبحاث والمقالات العلمية والأطروحات الجامعية والكتب والأبحاث باللغة العربية، وتحديد درجة التشابه أو أصالة الأعمال البحثية وحماية ملكيتها الفكرية. تعرف اكثر